💹 Your Post-Notable Earnings Report (Dec 4)

Open Email...Your Morning Report Inside…Post Earnings for Major Stocks [Your Notable Earnings Report]( [Unsubscribe]( [🎯 Limited Chance for Investors Looking for a Potential Biotech Windfall (ad)**]( Dear Reader, I hope you are having a great Wednesday! I am sending you the list of major stocks which reported Earnings a few days ago with Earnings Surprise (to help you find Post-Earnings trading and/or investing opportunities). [Breakthrough Tech Set to Prevent Cybersecurity Catastrophe! (ad)*]( As global cyberwarfare intensifies, China, Russia, and North Korea race to unlock the ‘Master Key’ to the internet. If they succeed, every secret will be exposed. But one tech company has developed a game-changing solution to stop them. [Discover How in this Exclusive—get your FREE Report now!]( Symbol Company Earning Date EPS Surprise % [ZS]( 12/02 [after] 85.71% [ANF]( 11/26 [before] 7.76% [DDD]( 11/26 [before] -14.29% [NTNX]( 11/26 [before] 266.67% [BURL]( 11/26 [before] 0.65% [BBY]( 11/26 [before] -3.08% [DKS]( 11/26 [before] 2.61% [KSS]( 11/26 [before] -25.93% [URBN]( 11/26 [before] 29.41% [HPQ]( 11/26 [before] -1.06% [YY]( 11/26 [before] 27.85% [ADI]( 11/26 [before] 1.83% [AMBA]( 11/26 [after] 10.00% [CRWD]( 11/26 [after] 700.00% [JWN]( 11/26 [after] 43.48% [Click Here to View Your Full Report]( [sun] Before Market Open [sun] After Market Close [⚡ Breaking News: Elon Musk Invents New Type of AI (Shocking) (ad)]( According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… A man who picked 41 plays that jumped 1,000%+... Elon Musk is about to shock the world again with this new type of AI… Providing wealth-building opportunities in the process. [🔗 Click here to see the details]( [[Investor Alert] : $2 Trillion Cybersecurity Boom 💥 —Don't Miss Out! (ad)*]( Investor Megatrend Alert: Skyrocketing ransomware attacks and costly hacks are fueling a massive $2 trillion cybersecurity BOOM. Experts anticipate companies will shell out $1.5-$2 trillion annually in a desperate bid to protect their data. And one little-known company, armed with breakthrough technology, could be positioned to capture a significant share of this market. [Download your Special Report.]( How to use EPS Surprice in your Post-Earnings trading strategies: Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company’s earnings announcement) or the Price Reversal strategy (to target the reversal of next-day big price movement). Please click on [Ride-the-Wave Strategy]( to learn more about it. Stock Trading - If you’re a stock trader/investor or portfolio manager, you may want to consider adjusting your positiosn based on a EPS surprise reported by the company. At Daily Options Signals, we're really excited to help you trade more confidently. To that end, we’re constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. To your trading success, Support Team Daily Options Signals PS: Daily Options Signals is morning newsletter, powered by [StockEarnings]( proprietary technology. Daily Options Signals SMS is Here! Join SMS Text and never miss any stock trade alerts or special offers from Daily Options Signals and our advertising partners ever again... [Click right here to join Daily Options Signals SMS List]( (ad)* This message is a PAID ADVERTISEMENT for Scope Technologies Corp. (OTCQB: SCPCF/CSE: SCPE) from Creative Direct Marketing Group, Inc. StockEarnings, Inc. has received a fixed fee of $30,000 from Creative Direct Marketing Group, Inc. for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between December 2, 2024 and December 12, 2024. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Scope Technologies Corp. (OTCQB: SCPCF/CSE: SCPE) or Creative Direct Marketing Group, Inc. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Scope Technologies Corp. (OTCQB: SCPCF/CSE: SCPE) on The Investment Journal website for additional information about the relationship between Creative Direct Marketing Group, Inc. and Scope Technologies Corp. (OTCQB: SCPCF/CSE: SCPE). (ad)** This message is a PAID ADVERTISEMENT for BirchBioMed Inc. (Reg A+) from i2i Marketing Group, LLC. StockEarnings, Inc. has received a fixed fee of $4,000 from i2i Marketing Group, LLC. for multiple Email sends and Newsletter Sponsorships between December 02, 2024 and December 12, 2024. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either BirchBioMed Inc. (Reg A+) or i2i Marketing Group, LLC. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BirchBioMed Inc. (Reg A+) on BirchBioMed website for additional information about the relationship between i2i Marketing Group, LLC. and BirchBioMed Inc. (Reg A+). Daily Options Signals is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please [click here]( for SE Disclaimers. StockEarnings Inc. 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS [Unsubscribe]( [Today's Bonus Content: A massive catalyst is bearing down on us…]( (By clicking the link above you agree to periodic updates from Wealthpin and its partners ([privacy policy](